GP6 and Thrombocytopenia: Following the study of Fab fragments targeting GPVI, Li et al. reported an OM4 Fab antibody capable of inhibiting platelet aggregation induced by collagen in vitro and inhibiting thrombosis in vivo in rat models without increasing the bleeding time (at doses of 20 mg/kg); controversially, these doses induced acute thrombocytopenia [101].